48,466
edits
Difference between revisions of "Malignant melanoma"
Jump to navigation
Jump to search
→Sentinel lymph node panel
| Line 381: | Line 381: | ||
*MART-1. | *MART-1. | ||
*HMB-45. | *HMB-45. | ||
Notes: | |||
*Positive in approximately 20% of cases - based on one series.<ref name=pmid24455276>{{cite journal |author=Teixeira V, Vieira R, Coutinho I, ''et al.'' |title=Prediction of sentinel node status and clinical outcome in a melanoma centre |journal=J Skin Cancer |volume=2013 |issue= |pages=904701 |year=2013 |pmid=24455276 |pmc=3886376 |doi=10.1155/2013/904701 |url=}}</ref> | |||
**Strongly dependent on T-stage (T1 ~5%, T2 ~11%, T3 ~28%, T4 ~47%). | |||
===Others=== | ===Others=== | ||